GU Cancers 2019 | Analysis of OS based on early tumor shrinkage in the phase III METEOR study

Ignacio Duran

Ignacio Duran, MD, PhD, of the Hospital Universitario Virgen del Rocío, Seville, Spain, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA. He describes the rationale, design, results and conclusion of this important study in renacl cell carcinoma.

Share this video